Juno Therapeutics Inc (NASDAQ:JUNO) unveiled its new headquarters and research facility, located in the heart of South Lake Union in Seattle. The new headquarters brings together Juno’s Seattle employees …
David Nierengarten Re-evaluates JUNO; Upgrades Shares to Outperform
How Has a Deal Between Kite and Gilead Likewise Sent Juno Shares Jumping?
In a research report published Monday, BTIG analyst Dane Leone reiterated a Neutral rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO), after the …
Juno Therapeutics Inc (NASDAQ:JUNO) announced updated data from the TRANSCEND trial of JCAR017 in relapsed and refractory (r/r) aggressive B cell non-Hodgkin lymphoma …
Juno Therapeutics Inc (NASDAQ:JUNO) shares are dropping 7% following the biotech firm’s official termination of their JCAR015 program for the treatment of patients …
Juno Therapeutics Inc (NASDAQ:JUNO) reported financial results and business highlights for the fourth quarter and year ended December 31, 2016. “2016 was a …
Alcobra Ltd Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the top-line results from MEASURE, the company’s second Phase …
J.P.
Juno Therapeutics Inc (NASDAQ:JUNO) and Celgene Corporation (NASDAQ:CELG) announced that the U.S.